Furthermore, depletion of PPP1R26 by shRNA dramatically inhibits tumor growth in mouse xenografts in vivo, demonstrating that small molecules targeting PPP1R26 such as siRNA or chemical compound may provide a potential therapeutic strategy in the HCC treatment. The gene discussed is PPP1R26; the disease is hepatocellular carcinoma.